Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Fujian Province Clinical Research Center for Metabolic Diseases, Fuzhou, Fujian, China.
J Int Med Res. 2021 Sep;49(9):3000605211044366. doi: 10.1177/03000605211044366.
To identify independent risk factors for diabetic neuropathy (DN) in patients with type 2 diabetes mellitus (T2DM).
We retrospectively analyzed 376 patients with T2DM at the First Affiliated Hospital of Fujian Medical University, China between January 2013 and October 2016. Multivariate logistic regression was used to explore potential risk factors for progression of DN in patients with T2DM. Effect sizes were estimated using odds ratios (ORs) and 95% confidence intervals (CIs).
The prevalence of DN in patients with T2DM was 43.1%. Multivariate logistic regression indicated that retinopathy (OR: 2.755, 95% CI: 1.599-4.746); diabetic nephropathy (OR: 2.196, 95% CI: 1.279-3.772); longer duration of T2DM (OR: 1.081, 95% CI: 1.045-1.120); use of insulin (OR: 1.091, 95% CI: 1.018-1.170); longer history of alcohol consumption (OR: 1.034, 95% CI: 1.010-1.059); and higher blood urea nitrogen (OR: 1.081, 95% CI: 1.009-1.159) were associated with increased risk of DN in patients with T2DM.
Retinopathy, diabetic nephropathy, longer duration of T2DM, use of insulin, longer history of alcohol consumption, and higher blood urea nitrogen were independent risk factors for DN. These findings should be verified in large-scale prospective studies.
确定 2 型糖尿病(T2DM)患者发生糖尿病神经病变(DN)的独立危险因素。
我们回顾性分析了 2013 年 1 月至 2016 年 10 月期间在中国福建医科大学附属第一医院就诊的 376 例 T2DM 患者。采用多变量逻辑回归分析探讨 T2DM 患者 DN 进展的潜在危险因素。使用比值比(ORs)和 95%置信区间(CIs)估计效应大小。
T2DM 患者中 DN 的患病率为 43.1%。多变量逻辑回归分析表明,视网膜病变(OR:2.755,95%CI:1.599-4.746);糖尿病肾病(OR:2.196,95%CI:1.279-3.772);T2DM 病程较长(OR:1.081,95%CI:1.045-1.120);使用胰岛素(OR:1.091,95%CI:1.018-1.170);较长的饮酒史(OR:1.034,95%CI:1.010-1.059);以及较高的血尿素氮(OR:1.081,95%CI:1.009-1.159)与 T2DM 患者发生 DN 的风险增加相关。
视网膜病变、糖尿病肾病、T2DM 病程较长、使用胰岛素、较长的饮酒史和较高的血尿素氮是 DN 的独立危险因素。这些发现需要在大规模前瞻性研究中得到验证。